News | April 24, 2026
Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump
Growth was broad-based across segments
Growth was broad-based across segments
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Subscribe To Our Newsletter & Stay Updated
